VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Same old. Same old.

<< Previous

Bullboard Posts

Next >>

Comment by Xwing229on Sep 02, 2020 4:21pm

95 Views

Post# 31496400

RE:Same old. Same old.

New leadership at this point will kill the company. Last "new" leadership was ready to go into receivership. China won't come to the rescue they are a bunch of pathological liars. They have a product that seems to be useful for covid so I'm wondering why GA isn't banging the drum in every media in order to attract investors attention. He should be out there yelling like a madman that heart damage can be accurately and effectively with the vms.

<< Previous

Bullboard Posts

Next >>

Fueling the Future: Uranium market activity for the week of July 1